Aptevo Therapeutics Inc. (APVO) Price Chart

Aptevo Therapeutics (APVO) is an American biotech startup developing therapeutic antibodies to combat hematological diseases, leveraging the ADAPTIR modular toolkit. The company achieves a reduction in testing costs through strategic alliances with global behemoths and the development of the ADAPT platform. This chart available on the GURU.Markets page reflects a price level of 0.59. Company management strictly limits expenditures, focusing on validating the efficacy of its immuno-oncology developments.

aptevotherapeutics.com - APVO Price Chart (period 07/04/2022 - 11/15/2026)

Aptevo Therapeutics - analytical breakdowns and key metrics (APVO)

- stock quotes and analyst forecast:

Stock Price aptevotherapeutics.com|APVO - Analyst Consensus Forecast

- market capitalization details:

Market Value Aptevo|APVO - Full Business Value

- balance sheet equity data:

Accounting Value per Share Aptevo Therapeutics|APVO - Company Book Value|Market Value to Book Value Ratio aptevotherapeutics.com|APVO - Company Assets

- company total debt and liquidity indicators:

- financial results and valuation multiples details:

APVO - Net Income|Projected Future Earnings Aptevo Therapeutics|APVO - P/E Multiple|Projected Price to Earnings Aptevo Therapeutics, Inc.|APVO - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Aptevo Therapeutics Inc.|APVO - Operating income before deduction of amortization|Earnings per share for the last twelve months Aptevo Therapeutics|APVO - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months aptevotherapeutics.com|APVO - Net earnings per share growth this year|Expected earnings per share growth for next year Aptevo Therapeutics

- issuer revenue and sales details:

APVO - Revenue and Sales Volume|Company Projected Revenue Aptevo|APVO - Market Cap to Revenue Ratio|Forward P/S Multiple Aptevo Therapeutics, Inc.|APVO - Trailing Twelve Months Revenue Growth

Fundamental valuation:Aptevo Therapeutics, Inc.

The price reflects the market value of the business stake and serves as an indicator of listing status, where its dynamics discount the market's aggregate expectations regarding future cash flows. By analyzing fluctuations in exchange quotes, the investor assesses confidence in the success of the Aptevo Therapeutics (APVO) R&D pipeline, particularly concerning the advancement of clinical trials for bispecific antibodies for targeted immuno-oncology.

Analysis of competing companies